These disruptions include glucose metabolic disorders characterized by IR, sexual hormone metabolic disorders dominated by hyperandrogenism, abnormal bile acid metabolic pathways, IL-22 mediated intestinal immune dysfunction, and dysregulation of the brain-gut axis. Here, IL22 is linked to glucose metabolism disease.